Form 8-K · Current report
Target Corporation 8-K, filed Jul 22, 2026
- Filed
- CIK
- 0000027419
- Accession no.
- 0000027419-26-000028
Summary
Target Corporation's board elected Joe DePinto, former president and chief executive of 7-Eleven, as a director effective August 1, 2026, and appointed him to its Audit & Risk and Infrastructure & Finance committees. Target said the appointment supports its enterprise strategy under CEO Michael Fiddelke.
Key points
- DePinto led 7-Eleven as president and CEO from 2005 until December 2025 and previously served as president of GameStop.
- He will receive Target's standard non-employee director compensation.
- Target stated there are no arrangements or understandings between DePinto and any other person regarding his selection, and no related person transactions.
- Lead Independent Director Christine Leahy said DePinto's retail and omnichannel experience will add to the board's expertise.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 18, 2026, the Board of Directors of Target Corporation (“Target”) elected Joe DePinto as a director of Target, effective August 1, 2026. Mr. DePinto was also appointed to serve on the Audit & Risk Committee and the Infrastructure & Finance Committee, each also effective August 1, 2026. Mr. DePinto, 63, is the former President & Chief Executive Officer at 7-Eleven, Inc., a position he held from 2005 to December 2025. Prior to his role at 7-Eleven, Mr. DePinto was previously president of GameStop Corporation. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.